J&J Bounces Back: An Interview with Ashley McEvoy

article image

A wide-ranging discussion with J&J’s EVP and Worldwide Chairman of Medical Devices on how she plans to get Johnson & Johnson’s medtech mojo back.

Fifteen years ago, when Johnson & Johnson launched its historic $20 billion-plus offer for Guidant Corp., many medtech industry executives quietly cheered, if only because, they argued, it suggested the value that the healthcare giant was willing to place on medical devices.

Articles from David Cassak:

Investors & Dealmaking

Discovering New Sources of Capital for Medtech Start-Ups

While capital is still often difficult to find for many medtech start-ups, new investors are coming into the sector and could offer options for those companies that fit the right profile. We examine the investment strategies of Koch Disruptive Technologies, the NFL Players Association, and the NIH.

Read Article